Announcements
20 March 2026
Cancers | Myeloma Awareness Month
March is designated as Myeloma Awareness Month, a time when global activities aim to increase awareness of myeloma and support research and development efforts. We would like to take this opportunity to extend our sincere appreciation to all researchers who have contributed to the fight against this disease. In particular, we are pleased to share some of the high-quality and innovative research findings in the field of myeloma, as published in Cancers (ISSN: 2072-6694): We hope this announcement provides useful insights for those working in this area. The list of relevant papers can be found below.
1. “The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS)”
by Marco Parillo and Carlo Augusto Mallio
Cancers 2025, 17(2), 275; https://doi.org/10.3390/cancers17020275
2. “Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical Implications”
by Sihong Li, Jiahui Liu, Madeline Peyton, Olivia Lazaro, Sean D. McCabe, Xiaoqing Huang, Yunlong Liu, Zanyu Shi, Zhiqi Zhang, Brian A. Walker et al.
Cancers 2025, 17(4), 653; https://doi.org/10.3390/cancers17040653
3. “The Evolving Landscape in Multiple Myeloma: From Risk Stratification to T Cell-Directed Advanced Therapies”
by Carmen Besliu, Alina Daniela Tanase, Ionela Rotaru, Jose Espinoza, Laura Vidal, Martine Poelman, Manel Juan, Carlos Fernández de Larrea and Kamal S. Saini
Cancers 2025, 17(3), 525; https://doi.org/10.3390/cancers17030525
4. “Evolution of Survival in Patients with Multiple Myeloma over Two Decades: A Real-World Experience from a Medium-Level Hospital”
by Esther Ortega-Vida, Abel Rosado-Rodriguez, Rocio Fe, Victoria Verdugo, Rocio Gavira and Sebastián Garzón
Cancers 2025, 17(5), 793; https://doi.org/10.3390/cancers17050793
5. “Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review”
by Benjamin Derman, Carlyn Tan, Ian Steinfield, Florence R. Wilson, Dee Lin, Bingcao Wu, Mariana Fernandez, Jessica Fowler, Agne Paner-Straseviciute, Nina Kim et al.
Cancers 2025, 17(7), 1235; https://doi.org/10.3390/cancers17071235
6. “Predicting the Progression from Asymptomatic to Symptomatic Multiple Myeloma and Stage Classification Using Gene Expression Data”
by Nestoras Karathanasis and George M. Spyrou
Cancers 2025, 17(2), 332; https://doi.org/10.3390/cancers17020332
7. “Unveiling Extramedullary Myeloma Immune Microenvironment: A Systematic Review”
by Kassiani Boulogeorgou, Maria Papaioannou, Sofia Chatzileontiadou, Elisavet Georgiou, Amalia Fola, Sofia-Eleni Tzorakoleftheraki, Evdoxia Hatjiharissi and Triantafyllia Koletsa
Cancers 2025, 17(7), 1081; https://doi.org/10.3390/cancers17071081
8. “Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials”
by Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Panagiotis Malandrakis, Vassilis Koutoulidis, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos and Maria Gavriatopoulou
Cancers 2025, 17(12), 1943; https://doi.org/10.3390/cancers17121943
9. “T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS”
by Katia Mancuso, Marco Talarico, Enrica Manzato, Simona Barbato, Paola Tacchetti, Elena Zamagni and Michele Cavo
Cancers 2025, 17(9), 1514; https://doi.org/10.3390/cancers17091514
10. “Prognostic Value of Post-Transplant MRD Negativity in Standard Versus High- and Ultra-High-Risk Multiple Myeloma Patients”
by Lea Jasmin Kündgen, Dilara Akhoundova, Michele Hoffmann, Myriam Legros, Inna Shaforostova, Katja Seipel, Ulrike Bacher and Thomas Pabst
Cancers 2025, 17(9), 1565; https://doi.org/10.3390/cancers17091565
|
“Multiple Myeloma: From Molecular Insights to Clinical Treatment” |
“Myeloma and Immunology” |
20 March 2026
MDPI Webinar | March—Colorectal Cancer Awareness Month, 31 March 2026
To commemorate World Cancer Day 2026, MDPI is pleased to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique”, this series highlights how every story, discovery, and voice contributes to strengthening the global fight against cancer.
In our March session, we welcome leading voices in colorectal cancer research to share impactful insights, raise awareness, and highlight recent advances in prevention, diagnosis, and treatment.
Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts to address cancer worldwide. Together, we honor every patient’s journey, recognize every researcher’s contribution, and reinforce the power of collective action in the fight against cancer.
Date: 31 March 2026
Time: 3:00 p.m. CEST| 9:00 a.m. EDT | 9:00 p.m. CST (Asia)
Webinar ID: 812 1306 3619
Webinar Secretariat: journal.webinar@mdpi.com
Register now for free!
|
Speaker |
Presentation |
Time in CEST |
Time in EDT (US) |
|
|
MDPI Introduction |
3:00–3:10 p.m. |
9:00–9:10 a.m. |
|
Prof. Dr. Paola Patrignani |
The Crucial Role of Platelet Eicosanoids in Cancer: An Opportunity to Prevent Cancer Development and Metastasis Through Targeted Therapeutic Interventions |
3:10–3:30 p.m. |
9:10–9:30 a.m. |
|
Prof. Dr. William H. Gmeiner |
Improving Efficacy and Overcoming Resistance in Treatment of Liver-Metastatic Colorectal Cancer with CF10 |
3:30–3:50 p.m. |
9:30–9:50 a.m. |
|
Dr. Eva Martínez-Balibrea |
Translational Research in Colorectal Cancer: From Biomarkers to Therapeutic Targets and Immuno-Oncology Models |
3:50–4:10 p.m. |
9:50–9:10 a.m. |
|
Dr. Zoltán Wiener |
Interactions in the Tumor Microenvironment to Promote Colorectal Cancer Progression |
4:10–4:30 p.m. |
9:10–9:30 a.m. |
|
|
Q&A Session |
4:30–4:55 p.m. |
9:30–9:55 a.m. |
|
|
Closing of Webinar |
4:55–5:00 p.m. |
9:55–10:00 a.m. |
After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Webinar Keynote Speakers:
- Prof. Dr. Paola Patrignani, Department of Neuroscience, Imaging and Clinical Sciences, Systems Pharmacology Laboratory (CAST), “G. d’Annunzio” University School of Medicine, Chieti, Italy;
- Prof. Dr. William Gmeiner, Department of Cancer Biology, Wake Forest University School of Medicine, North Carolina, USA;
- Dr. Eva Martínez-Balibrea, ProCURE and CARE programs from the Catalan Institute of Oncology and the Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain;
- Dr. Zoltán Wiener, Institute of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
20 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Systematic Review or Meta-Analysis in Cancer Research” Section
18 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Cancer Immunology and Immunotherapy” Section
18 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Cancer Biomarkers” Section
18 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Cancer Metastasis” Section
18 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Infectious Agents and Cancer” Section
18 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Tumor Microenvironment” Section
17 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Methods and Technologies Development” Section
17 March 2026
Cancers | Feature Papers from the First Half of 2025 in the “Cancer Informatics and Big Data” Section
